Literature DB >> 3986580

The development of the dorsal root potential and the responsiveness of primary afferent fibers to gamma-aminobutyric acid in the spinal cord of rat fetuses.

N Seno, K Saito.   

Abstract

The development of the dorsal root potential (DRP) and the responsiveness of primary afferent fibers to gamma-aminobutyric acid (GABA) were investigated in the isolated spinal cord of rat fetuses. At embryonic day 15.5, stimulation of the lumbar dorsal root was first effective in eliciting the DRP, which was not inhibited by bicuculline. A bicuculline-sensitive component of the DRP appeared at embryonic day 17.5. GABA (10 microM to 1 mM) caused a dose-dependent depolarization of the primary afferent fibers from embryonic day 13.5. The amplitude of the depolarization gradually increased with age until embryonic day 17.5 and was maintained thereafter. If the bicuculline-sensitive DRP solely reflects GABAergic activity, it is suggested that GABAergic activity develops at embryonic day 17.5 and the development of the responsiveness of primary afferent fibers to GABA precedes the functional onset of GABAergic neurons.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986580     DOI: 10.1016/0165-3806(85)90127-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Differential contributions of adenosine to hypoxia-evoked depressions of three neuronal pathways in isolated spinal cord of neonatal rats.

Authors:  K Otsuguro; M Wada; S Ito
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

2.  Development of non-cholinergic, non-adrenergic excitatory and inhibitory responses to intramural nerve stimulation in rat stomach.

Authors:  S Ito; A Kimura; A Ohga
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

3.  GABAergic modulation of a substance P-mediated reflex of slow time course in the isolated rat spinal cord.

Authors:  H Akagi; M Yanagisawa
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.